Background illustration for clinical trials search

Paid Clinical Trials Fort Wayne

Discover 113 paid clinical trials in Fort Wayne, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

for
Metastatic Bone Disease
Location: Fort Wayne IN, Cincinnati OH, Aurora CO, Portland OR
Sponsor: Michelle Ghert, MD

Sex: All

Age: 18+

Code: NCT06863129

Recruiting

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

for
Neoplasm, Colorectal, Cognitive Impairment,
Location: Fort Wayne IN
Sponsor: Joseph McCollom

Sex: All

Age: 18+

Code: NCT05014399

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Fort Wayne IN, Lafayette IN, Edgewood KY, Evanston IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Fort Wayne IN, Grand Rapids MI, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Fort Wayne IN, Maumee OH, Ann Arbor MI, Dyer IN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Wayne IN, Columbus OH, Cincinnati OH, Milwaukee WI,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase 3, Recruiting

Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip

for
GI Bleeding, Perforation Colon, Perforation Bowel,
Location: Fort Wayne IN, Orlando FL
Sponsor: AdventHealth

Sex: All

Age: 18+

Code: NCT05852457

Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for
Ovarian Neoplasms, Ovarian Cancer
Location: Fort Wayne IN, Indianapolis IN, Hilliard OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07318558

Phase 3, Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Fort Wayne IN, Greenville OH, Troy OH, Kalamazoo MI,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase 3, Recruiting

Letrozole in Uterine Leiomyosarcoma

for
Uterine Leiomyosarcoma
Location: Defiance OH, Perrysburg OH, Adrian MI, Sylvania OH,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05649956

Phase 2, Recruiting

Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy

for
Radiculopathy Lumbar, Radiculopathy Sacral,
Location: Portland IN, Shepherdsville KY, Bardstown KY,
Sponsor: NeuFit - Neurological Fitness and Education

Sex: All

Age: 18+

Code: NCT06421558

Recruiting

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Goshen IN, Maumee OH, Hinsdale IL, Canton OH, Peoria IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Goshen IN, Ann Arbor MI, Cincinnati OH, O'Fallon IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

for
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Goshen IN, Columbus OH, Cincinnati OH, Dallas TX
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04502394

Phase 1, Phase 2, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,
Location: Goshen IN, Greenville OH, Troy OH, Kalamazoo MI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase 3, Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Goshen IN, Lima OH, Findlay OH, Perrysburg OH,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Goshen IN, Greenville OH, Troy OH, Kalamazoo MI,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Goshen IN, Niles MI, Sylvania OH, Jackson MI, Toledo OH,
Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Goshen IN, Kettering OH, Cincinnati OH, Chicago IL,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Goshen IN, Niles MI, Battle Creek MI, Sylvania OH,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase 3, Recruiting